These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1471224)

  • 1. Cell injury and death caused by bacterial protein toxins.
    Donelli G; Fiorentini C
    Toxicol Lett; 1992 Dec; 64-65 Spec No():695-9. PubMed ID: 1471224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial toxins: friends or foes?
    Schmitt CK; Meysick KC; O'Brien AD
    Emerg Infect Dis; 1999; 5(2):224-34. PubMed ID: 10221874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli cytotoxins and enterotoxins.
    Gyles CL
    Can J Microbiol; 1992 Jul; 38(7):734-46. PubMed ID: 1393838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Escherichia coli cytotoxic necrotizing factor type 1 (CNF1) with cultured cells.
    Falzano L; Fiorentini C; Boquet P; Donelli G
    Cytotechnology; 1993; 11 Suppl 1():S56-8. PubMed ID: 7763759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumor necrosis factor and nitric oxide in the cytotoxic effects of Clostridium difficile toxin A and toxin B on macrophages.
    Melo Filho AA; Souza MH; Lyerly DM; Cunha FQ; Lima AA; Ribeiro RA
    Toxicon; 1997 May; 35(5):743-52. PubMed ID: 9203299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoskeletal changes induced in HEp-2 cells by the cytotoxic necrotizing factor of Escherichia coli.
    Fiorentini C; Arancia G; Caprioli A; Falbo V; Ruggeri FM; Donelli G
    Toxicon; 1988; 26(11):1047-56. PubMed ID: 3072687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L.
    Baldacini O; Girardot R; Green GA; Rihn B; Monteil H
    Toxicon; 1992 Feb; 30(2):129-40. PubMed ID: 1557784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological changes in adherent cells induced by Clostridium difficile toxins.
    von Eichel-Streiber C; Warfolomeow I; Knautz D; Sauerborn M; Hadding U
    Biochem Soc Trans; 1991 Nov; 19(4):1154-60. PubMed ID: 1794484
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis.
    Arnon SS; Mills DC; Day PA; Henrickson RV; Sullivan NM; Wilkins TD
    J Pediatr; 1984 Jan; 104(1):34-40. PubMed ID: 6690674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
    Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
    J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
    Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
    J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of okadaic acid on the cytotoxic activity of Clostridium difficile toxin B and Clostridium sordellii toxin L.
    Baldacini O; Lutun P; Girardot R; Monteil H
    Nat Toxins; 1993; 1(6):361-8. PubMed ID: 8167958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
    Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD
    J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytopathic effects of shigellae on Vero & HeLa cells.
    Ramachandran VG; Varghese A; Agarwal DS
    Indian J Med Res; 1983 Aug; 78():161-9. PubMed ID: 6654406
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.
    Chaves-Olarte E; Weidmann M; Eichel-Streiber C; Thelestam M
    J Clin Invest; 1997 Oct; 100(7):1734-41. PubMed ID: 9312171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Escherichia coli cytotoxic necrotizing factor 1 on repair of human bladder cell monolayers in vitro.
    Island MD; Cui X; Warren JW
    Infect Immun; 1999 Jul; 67(7):3657-61. PubMed ID: 10377155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial toxins modifying the actin cytoskeleton.
    Richard JF; Petit L; Gibert M; Marvaud JC; Bouchaud C; Popoff MR
    Int Microbiol; 1999 Sep; 2(3):185-94. PubMed ID: 10943412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
    Lamont JT
    Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.
    Wang S; Rustandi RR; Lancaster C; Hong LG; Thiriot DS; Xie J; Secore S; Kristopeit A; Wang SC; Heinrichs JH
    Vaccine; 2016 Mar; 34(10):1319-23. PubMed ID: 26614590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.